In NSCLC, liquid biopsies with detected EGFR driver mutations, ALK, RET, and ROS1 fusions, and MET exon 14 skipping mutations tended to have bTMB<10, similarly to NSCLC tissue biopsies (Fig. 3A). This evidence concerns the gene ALK and non-small cell lung carcinoma.